Pages that link to "Q50745207"
Jump to navigation
Jump to search
The following pages link to The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings (Q50745207):
Displaying 50 items.
- Offering an American graduate medical HIV course to health care workers in resource-limited settings via the Internet (Q21133784) (← links)
- Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010 (Q21134515) (← links)
- Estimating the capacity for ART provision in Tanzania with the use of data on staff productivity and patient losses (Q21143796) (← links)
- Has the DOTS strategy improved case finding or treatment success? An empirical assessment (Q21144342) (← links)
- Low dose versus high dose stavudine for treating people with HIV infection (Q24186488) (← links)
- Rilpivirine versus efavirenz for initial therapy in treatment-naive, HIV-1-infected patients (Q24201421) (← links)
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy (Q24234853) (← links)
- Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals (Q24236476) (← links)
- Low dose versus high dose stavudine for treating people with HIV infection (Q24242088) (← links)
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy (Q24243499) (← links)
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy (Q24245940) (← links)
- Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis (Q26828443) (← links)
- Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries (Q27001286) (← links)
- Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared (Q28473120) (← links)
- Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal (Q28476337) (← links)
- HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high (Q28476627) (← links)
- Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings (Q28478154) (← links)
- Young HIV-Infected Children and Their Adult Caregivers Prefer Tablets to Syrup Antiretroviral Medications in Africa (Q28483158) (← links)
- Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda (Q28535266) (← links)
- High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa (Q28535483) (← links)
- Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples (Q28539725) (← links)
- HIV-1 diversity, transmission dynamics and primary drug resistance in Angola (Q28542528) (← links)
- Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique (Q28546341) (← links)
- Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study (Q28550552) (← links)
- Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe (Q28730357) (← links)
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model (Q29305377) (← links)
- Managing the Personal Side of Health Care among Patients with HIV/AIDS. (Q30207536) (← links)
- Health systems' responses to the roll-out of antiretroviral therapy (ART) in India: a comparison of two HIV high-prevalence settings (Q30227030) (← links)
- Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals (Q30240127) (← links)
- Can the Success of HIV Scale-Up Advance the Global Chronic NCD Agenda? (Q30240145) (← links)
- Modifications to ART service delivery models by health facilities in Uganda in promotion of intervention sustainability: a mixed methods study (Q30377774) (← links)
- Getting to 90-90-90 in paediatric HIV: What is needed? (Q30385352) (← links)
- HIV/AIDS, chronic diseases and globalisation (Q30406434) (← links)
- NGO-provided free HIV treatment and services in Burkina Faso: scarcity, therapeutic rationality and unfair process (Q30413878) (← links)
- Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda (Q30438445) (← links)
- Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda (Q30445335) (← links)
- Miniaturized lensless imaging systems for cell and microorganism visualization in point-of-care testing. (Q30470842) (← links)
- Consolidating emerging evidence surrounding HIVST and HIVSS: a rapid systematic mapping protocol (Q30491328) (← links)
- Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial (Q30539434) (← links)
- Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects (Q30861852) (← links)
- The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling (Q33323442) (← links)
- Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. (Q33459535) (← links)
- Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review (Q33470290) (← links)
- Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? (Q33520008) (← links)
- Transmitted drug resistance in nonsubtype B HIV-1 infection (Q33567164) (← links)
- The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations (Q33570778) (← links)
- Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis. (Q33584656) (← links)
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial (Q33587553) (← links)
- Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial (Q33590533) (← links)
- Highly active antiretroviral treatment for the prevention of HIV transmission (Q33657373) (← links)